Tumor Necrosis Factor α Blockers and the Risk of Multiple Sclerosis

Neurology. 2023 Feb 7;100(6):267-268. doi: 10.1212/WNL.0000000000201629. Epub 2022 Oct 28.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Canada
  • Humans
  • Multiple Sclerosis* / drug therapy
  • Research
  • Tumor Necrosis Factor-alpha

Substances

  • Tumor Necrosis Factor-alpha